← All patents

US20260102335A1

Immune cells expressing engineered antigen receptors

University of Texas System

Abstract

Provided herein are immune cells expressing antigenic receptors, such as a chimeric antigen receptor and a T cell receptor. Further provided herein are methods of treating immune-related disorder by administering the antigen-specific immune cells.

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Katy REZVANI
Priority date
April 19, 2017
Filing date
December 12, 2025
Publication date
April 16, 2026
Language
en
Metadata fetched
August 29, 2026 00:37